AFO vs FES for Drop Foot After Stroke: Which Should You Choose?

NeuroRehab Team
Thursday, August 20th, 2026

AFOFESfoot drop

---

---

AFO vs FES for Drop Foot After Stroke: Which Is the Better Choice for Your Recovery?

Drop foot is one of the most common walking impairments after stroke. When the muscles that lift the foot during walking are weakened or paralysed, the foot drags or catches on the ground with each step, significantly increasing the risk of falls and limiting walking speed, endurance, and independence.

Two treatment options are used most widely: ankle foot orthoses (AFOs) and functional electrical stimulation (FES) devices. Both help stroke survivors walk more safely. But they work in fundamentally different ways, produce different outcomes, and suit different people at different stages of recovery.

Understanding the difference matters because the choice between them is not simply a preference. It affects whether you are managing a symptom or actively driving neuroplastic recovery. This guide explains how each works, what the evidence says, and how to think about which option is right for your situation. For a broader understanding of how electrical stimulation supports stroke recovery overall, see our complete electrode placement guide for stroke recovery.

What Is Drop Foot After Stroke?

Drop foot, also called foot drop, is the inability to lift the front part of the foot during the swing phase of walking. In a normal walking pattern, the ankle dorsiflexors, primarily the tibialis anterior muscle on the front of the lower leg, contract to lift the foot clear of the ground as the leg swings forward. When stroke damages the motor pathways controlling these muscles, this lift is partially or completely lost.

The result is a foot that drags, catches, or slaps the ground with each step. To compensate, many survivors develop a circumduction pattern, swinging the affected leg out to the side in a wide arc to clear the foot from the ground. Others hike the hip upward on the affected side. These compensatory patterns are tiring, reduce walking speed, and place abnormal stress on the hip and knee.

Drop foot after stroke is associated with significantly increased fall risk, reduced walking speed, reduced walking endurance, and reduced community participation. Effective management is therefore not just about comfort. It is directly relevant to safety and quality of life.

What Is an AFO?

An ankle foot orthosis is a rigid or semi-rigid brace worn on the lower leg and foot that mechanically holds the ankle in a neutral or slightly dorsiflexed position. It works by providing external structural support to the ankle joint, preventing the foot from dropping during the swing phase of walking.

AFOs are typically made from polypropylene or carbon fibre and are custom-moulded to the survivor’s foot and lower leg, although off-the-shelf versions are also available. They fit inside a shoe, usually requiring a shoe half a size larger than normal to accommodate the brace.

The key characteristic of an AFO is that it is a passive device. It does not stimulate any muscle activity. It simply holds the foot in position mechanically. The muscles that should be doing this job receive no stimulus from the AFO and are not being exercised or rehabilitated during its use.

What Is FES for Drop Foot?

Functional electrical stimulation for drop foot is a device that delivers electrical impulses to the peroneal nerve or tibialis anterior muscle during walking, causing the ankle dorsiflexors to contract and lift the foot at the correct point in the walking cycle. Modern FES devices use a heel sensor, an accelerometer, or a tilt sensor to detect the moment of heel lift at the start of the swing phase and trigger the stimulation automatically at the right time.

Unlike an AFO, FES is an active device. It works by stimulating the muscles and nerves that should be producing the movement, rather than providing external mechanical support in their place. The electrical stimulation triggers real muscle contractions, and when combined with the survivor’s simultaneous voluntary effort to lift the foot, it drives neuroplastic changes in the motor pathways that can lead to improved voluntary dorsiflexion over time.

FES for drop foot therefore serves two purposes simultaneously: it provides immediate functional assistance during walking, comparable to an AFO, and it delivers a therapeutic stimulus that can drive ongoing motor recovery. This dual function is the central argument for FES over AFO in stroke rehabilitation.

How They Compare: The Evidence

Research comparing AFOs and FES devices for drop foot after stroke has produced a consistent picture across multiple trials and systematic reviews.

Immediate walking improvement

Both AFOs and FES devices produce immediate improvements in walking speed, step length, and safety compared to walking without any assistance. Studies comparing the two directly have generally found equivalent immediate functional benefit, meaning both options help you walk better right now to a similar degree.

Some studies show a slight advantage for FES in walking speed and energy efficiency compared to AFO, particularly in survivors who have some residual voluntary dorsiflexion. The FES-assisted gait tends to look more normal than AFO-assisted gait because the foot lift is produced by real muscle contraction rather than mechanical bracing, resulting in a more natural swing phase.

Neuroplastic or therapeutic effect

This is where the two options diverge most significantly. Multiple studies have found that regular use of FES for drop foot produces improvements in voluntary dorsiflexion that persist even when the device is removed. This is called a carry-over or therapeutic effect. Survivors using FES consistently show improvements in walking ability without the device over time, suggesting that neuroplastic changes in the motor pathways are occurring.

AFOs produce no therapeutic effect. Walking with an AFO does not improve voluntary dorsiflexion because the muscles responsible are not being stimulated. The AFO simply compensates for the weakness without addressing it. When the AFO is removed, the underlying impairment is unchanged. This is the fundamental difference between the two approaches: one manages the symptom while the other also treats the underlying impairment.

Research on neuroplasticity consistently shows that recovery requires repetitive activation of the affected neural pathways. FES provides this activation during every step of every walk. An AFO does not. For more on how neuroplasticity drives stroke recovery, see our guide to neuroplasticity after stroke.

Fall risk and safety

Both devices reduce fall risk compared to unassisted walking with drop foot. Some studies suggest FES may have a slight advantage in reducing fall frequency over longer follow-up periods, potentially because of the carry-over improvement in voluntary dorsiflexion that reduces the degree of drop foot even when the device is not being used.

Comfort and compliance

AFOs are generally well-tolerated by most users once fitted correctly. Common complaints include skin pressure and irritation, difficulty fitting into shoes, and discomfort in warm weather. Compliance is generally high once the initial adjustment period has passed.

FES devices have a longer adjustment period and require more active management including electrode placement, parameter adjustment, and battery charging. Some users find the sensation of electrical stimulation uncomfortable initially, although most adapt within a few weeks. Compliance varies more with FES than with AFOs, and some survivors abandon FES devices before allowing enough time to experience the therapeutic benefit.

A Simple Comparison

Feature	AFO	FES Device
How it works	Mechanical bracing holds foot in position	Electrical stimulation activates dorsiflexor muscles
Immediate walking benefit	Yes, equivalent to FES	Yes, equivalent to AFO
Therapeutic / neuroplastic effect	None	Yes, carry-over improvement in voluntary movement
Muscle activity during use	No stimulus to affected muscles	Active muscle contractions with every step
Ease of use	Simple, no setup required	Requires electrode placement and device setup
Gait appearance	Mechanical, may look rigid	More natural, produced by real muscle activity
Cost	Lower, especially for off-the-shelf versions	Higher upfront cost, some insurance coverage available
Best suited for	Severe drop foot with no voluntary movement, or where FES is not tolerated	Survivors with some residual voluntary dorsiflexion and motivation to drive ongoing recovery

Who Is Each Option Best Suited For?

The choice between AFO and FES is not one-size-fits-all. Several factors influence which option is most appropriate for a given survivor at a given stage of recovery.

AFO is likely the better starting point when

• Drop foot is severe with no residual voluntary dorsiflexion and the priority is immediate walking safety
• The survivor has significant cognitive impairment that makes managing an FES device difficult
• Skin sensation in the lower leg is significantly impaired, increasing the risk of skin damage from electrical stimulation
• The survivor has a pacemaker or other implanted electrical device that contraindicate electrical stimulation
• Cost or access to FES devices is a limiting factor
• The survivor is in the very early acute phase when walking rehabilitation is just beginning

FES is likely the better choice when

• Some residual voluntary dorsiflexion is present, even if minimal, as this is the strongest predictor of FES response
• The survivor is motivated to drive ongoing recovery rather than simply manage the current level of impairment
• The survivor is in the sub-acute or chronic phase of recovery and neuroplastic recovery is still the goal
• Walking speed, energy efficiency, and gait quality are priorities alongside safety
• The survivor is willing to invest the time to learn correct electrode placement and device management

Using both together

AFO and FES are not mutually exclusive. Many survivors benefit from using an AFO for situations where setting up an FES device is impractical, such as short walks around the house or in the middle of the night, while using FES for dedicated walking practice sessions where the therapeutic benefit is the priority. This combined approach maximises both convenience and neuroplastic stimulus.

The Role of Voluntary Movement in FES Effectiveness

The single strongest predictor of how well a survivor will respond to FES for drop foot is whether any residual voluntary dorsiflexion is present. Even a very small amount of voluntary ankle lift, perhaps just a few degrees of movement or a flicker of tibialis anterior activity on electromyography, significantly improves the likelihood of a meaningful therapeutic response to FES.

This is because FES is most effective when the electrical stimulus and the survivor’s voluntary motor effort occur simultaneously. When both are present, the brain receives sensory feedback from the contracting muscle while the motor cortex is actively trying to produce the movement. This combination is the strongest possible stimulus for neuroplastic change in the affected motor pathway.

When no voluntary movement whatsoever is present, FES still provides functional walking assistance but the therapeutic effect on the underlying motor impairment is more limited. In this situation, an AFO may be the more practical primary device while other rehabilitation approaches target the underlying motor impairment in parallel.

For survivors unsure whether residual voluntary movement is present, a physiotherapist can assess this with specific tests including manual muscle testing and electromyography. It is worth having this assessment before concluding that FES is not an option. Understanding how electrical stimulation interacts with voluntary movement is central to getting the most from any electrical stimulation treatment. Our NMES vs TENS comparison guide covers these principles in more detail.

Practical Considerations for FES Use

If you are considering FES for drop foot, here are the practical factors to understand before starting:

Electrode placement. For drop foot, electrodes are typically placed over the common peroneal nerve at the fibular head (the bony prominence on the outer side of the knee) and over the tibialis anterior muscle on the front of the lower leg. Correct placement is critical for producing a good dorsiflexion response. A physiotherapist should guide initial electrode placement and parameter setting.

Walking speed and terrain. FES devices work best on flat surfaces at consistent walking speeds. Stairs, uneven terrain, and variable speeds require more management and practice to use safely with FES. Begin FES walking practice on flat, clear surfaces before progressing to more challenging environments.

Allow an adjustment period. Most survivors need two to four weeks of daily FES use before they feel comfortable and confident with the device. The stimulation sensation, the timing of foot lift, and the management of the device all take time to feel natural. Do not judge the device in the first few days.

Combine with active rehabilitation. FES during walking is most effective when combined with a broader lower limb rehabilitation program including strengthening exercises for the dorsiflexors, balance training, and progressive walking challenges. FES walking alone without additional rehabilitation produces slower neuroplastic gains than FES combined with a structured exercise program. For guidance on building a comprehensive stroke rehabilitation routine, see our post on stroke recovery milestones and what to expect at each stage.

What the Stroke Rehabilitation Guidelines Say

Current clinical guidelines from major rehabilitation bodies including the American Heart Association and the Royal College of Physicians support the use of both AFOs and FES for drop foot after stroke, with several key recommendations:

FES is recommended as a treatment option for drop foot in stroke survivors who have some residual voluntary dorsiflexion and are motivated to use the device consistently. The evidence base is classified as moderate to strong across multiple guidelines.

AFOs are recommended as the primary assistive device for walking safety in acute and sub-acute stroke survivors with drop foot, particularly when cognitive or sensory factors make FES management difficult.

Guidelines consistently recommend that the choice of device should be made individually based on the survivor’s level of voluntary movement, cognitive ability, motivation, skin sensation, and rehabilitation goals, rather than applying a single recommendation to all survivors. A physiotherapist with experience in stroke rehabilitation should guide this decision.

The wider evidence base for electrical stimulation in stroke recovery, including both upper and lower limb applications, is reviewed in detail in our guide to electrical stimulation electrode placement for stroke recovery.

Common Questions About AFO and FES for Drop Foot

Can I switch from an AFO to FES after using an AFO for a long time?

Yes. FES remains effective in the chronic phase of stroke recovery and survivors who have been using AFOs for months or years can still benefit from switching to or adding FES. The neuroplastic potential that makes FES effective does not disappear over time. A physiotherapist can assess whether residual voluntary dorsiflexion is present and advise on whether FES is likely to produce benefit at your current stage of recovery.

Is FES covered by insurance or Medicare?

Coverage varies significantly by country, insurer, and individual policy. In the United States, some FES devices for drop foot have received Medicare coverage in specific circumstances. It is worth checking with your specific insurer and with the device supplier, as coverage rules change and many suppliers can advise on reimbursement pathways. Your rehabilitation team may also be able to support a coverage request with appropriate clinical documentation.

How long does it take to see a therapeutic effect from FES?

Research studies typically assess therapeutic outcomes after six to twelve weeks of consistent daily FES use. Some survivors notice improvements in voluntary dorsiflexion within the first four to six weeks. Others see changes more gradually over three to six months. Consistency of use is the strongest predictor of therapeutic response. Using FES only occasionally is unlikely to produce meaningful neuroplastic change.

Does an AFO prevent recovery from drop foot?

An AFO does not actively prevent recovery, but it does not contribute to it either. The muscles responsible for dorsiflexion receive no therapeutic stimulus during AFO use. This is not harmful in itself, but it means that recovery of voluntary dorsiflexion, if it is going to occur, must come from other rehabilitation activities rather than from AFO use itself. Survivors using AFOs who want to maximise their chance of voluntary recovery should supplement AFO use with targeted dorsiflexor strengthening exercises and, where possible, FES during dedicated rehabilitation sessions.

Can I use FES if I have spasticity in my calf muscles?

Yes, in most cases. Calf spasticity and drop foot can coexist because different muscle groups are affected. FES targets the dorsiflexors on the front of the lower leg, not the spastic calf muscles on the back. However, if calf spasticity is severe, it may resist the dorsiflexion produced by FES and limit the range of foot lift achievable. In this situation, managing the spasticity through stretching, splinting, or other interventions alongside FES use produces better outcomes. See our guide to post-stroke spasticity treatment for management options.

Key Takeaways

• Drop foot after stroke causes the foot to drag during walking, significantly increasing fall risk and limiting mobility and independence.
• AFOs provide immediate mechanical walking assistance by bracing the ankle in a lifted position but produce no therapeutic effect on the underlying motor impairment.
• FES devices provide equivalent immediate walking assistance while also driving neuroplastic recovery through active muscle stimulation with every step.
• The presence of residual voluntary dorsiflexion, even minimal, is the strongest predictor of a good therapeutic response to FES.
• AFOs and FES are not mutually exclusive. Many survivors benefit from using both for different situations and purposes.
• FES requires a longer adjustment period and more active management than AFOs but produces outcomes that AFOs cannot match in terms of long-term motor recovery.
• The choice between AFO and FES should be made with a physiotherapist based on the individual survivor’s level of voluntary movement, cognitive ability, motivation, and rehabilitation goals.
• FES remains effective in the chronic phase of stroke recovery. It is never too late to consider it as an option.

Related Reading

• Complete Electrode Placement Guide for Stroke Recovery
• NMES vs TENS After Stroke: Which Should You Use?
• Neuroplasticity After Stroke: How Your Brain Rewires Itself
• Post-Stroke Spasticity Treatment: Evidence-Based Options
• Stroke Recovery Milestones: What to Expect Month by Month
• Electrical Stimulation Electrode Placement for Stroke Recovery

---

---